• The study narrowly missed statistical significance on the primary endpoint
• Pre-specified adjustment of COVID-19 impact, the study showed a statistically significant advantage
• The totality of evidence suggests that Ferinject® is clinically beneficial in high risk heart failure patients

Regulatory News:

Vifor Pharma today announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject®"...

Cortec Corporation’s ‘green’ packaging alternative, Eco-Corr Film, is now used to wrap automotive engines being moved from their manufacturing facilities in the Czech Republic for ocean transport.

Cortec, a leader in corrosion protection solutions, has dedicated years of its research to develop green, sustainable alternatives to conventional polyethylene"...

A few days after Gaza’s Health Ministry warned against the shortage of COVID-19 testing swabs, UN Special Coordinator for the Middle East Peace Process Nickolay Mladenov hailed the World Health Organisation in Occupied Palestinian Territory on Monday for supplying Gaza with more testing kits.

In a tweet, Mladenov thanked the organisation “for maintaining a steady supply of #COVID19 materials in response to the acute shortages in #Gaza.”

Ayman Al-Halabi, Director of the Support Medical Services Department at the Ministry of Health in the Gaza Strip, stated that the ministry suffers from severe shortage in the number of swabs used to examine the emerging corona virus.

Al-Halabi indicated in radio statements, on Saturday, that the swabs available at the Ministry of Health are enough for 48 hours only, pointing out that the DNA testing tools for the Corona virus are sufficient for"...

JENIN, Sunday, September 20, 2020 (WAFA) – Governor of Jenin, Akram Rajoub, ordered today a four-day lockdown of the town of Meithalun in the Jenin Governorate, north of the West Bank, following a rapid surge in coronavirus cases.

Rajoub said in a statement that the town will be locked down in order for the preventive medicine teams to conduct the necessary coronavirus tests, so as to prevent a wider outbreak of the pandemic in the town and"...

(WAFA) - The Italian Ministry of Foreign Affairs and International Cooperation, the Italian Agency for Development Cooperation (AICS), and UNICEF today signed a partnership for reaching vulnerable children and their families with essential integrated child protection and mental health psychosocial support in the Gaza Strip.

The agreement was signed by Giuseppe Fedele, Consul General of Italy in Jerusalem, and Lucia Elmi, UNICEF Special Representative"...

Octapharma is pleased to announce that the first site for the international PRO-SID (Primary Infection Prophylaxis with Panzyga® in Secondary Immunodeficiency in Chronic Lymphocytic Leukaemia) study was initiated in Milan, Italy, and patient recruitment is underway. Additional sites across Europe (Italy, Poland, Denmark, Hungary, Germany and Russia) and the USA are expected to begin recruitment soon. PRO-SID is the first randomised, placebo-controlled study to systematically evaluate the efficacy and safety of IVIG for"...

• Vifor Pharma to sell 100% of OM Pharma to Optimus Holding Ltd. for a consideration of MCHF 435
• In addition Vifor Pharma obtains an earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity which could increase the total transaction value in excess of MCHF 500
• Closure of the transaction is expected within 30 days
• Divestment strengthens Vifor Pharma’s focus on becoming the global leader in iron deficiency, nephrology and cardio-renal therapies

Regulatory"...

• First clinical study to evaluate novel combination blocking KRAS G12C and its activator SOS1 to potentially increase the therapeutic benefit for lung and colorectal cancer patients
• Study is based on preclinical evidence suggesting synergistic effect of KRAS G12C and SOS1 inhibition

Boehringer Ingelheim and Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced a clinical collaboration to evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor blocking KRAS independent of mutation"...